CervoMed Strengthens Board with Appointment of Life Sciences Business Strategy Leader David Quigley
(NASDAQ:CRVO), Mr. Quigley most recently led McKinsey & Company's Private Capital practice and previously led various Life Sciences practices at the firm Appointment adds deep business strategy, transactional, and commercial expertise as CervoMed prepares for Phase 3 and commercialization planning BOSTON, Oct. 28, 2025 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO) (CervoMed or the Company), […]